Latest News - Allergan

Thursday, April 06, 2017 | Personnel/Company News, Allergan

Allergan Taps Daphne Karydas as Senior Vice President of Global Investor Relations & Strategy

Daphne Karydas is Allergan’s new Senior Vice President of Global Investor Relations and Strategy, effective April 17, 2017.   In this role, Ms. Karydas will lead the Company's engage…

Read the full story

Thursday, April 06, 2017 | Acquisitions and Mergers, Allergan , Zeltiq

Allergan and ZELTIQ Announce Expiration of Hart-Scott-Rodino Waiting Period for Pending Transaction

Allergan is now one step closer to officially acquiring Zeltiq. The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the "HSR Act") has expired with respect …

Read the full story

Monday, March 20, 2017 | FDA Approval/Clearance, PracticalDermatology.com, Allergan

Juvéderm Vollure XC FDA Approved for Correction of Facial Wrinkles and Folds

The FDA has approved Allergan plc's Juvéderm Vollure XC for correction of moderate to severe facial wrinkles and folds, such as nasolabial folds, in adults over the age of 21. In the US piv…

Read the full story

Tuesday, March 14, 2017 | PracticalDermatology.com, Allergan

Survey: Many Bothered By Double Chins, Take Steps To Cover Up

Close to 50 percent of individuals are bothered by the appearance of the area under their chin, and many alter their behavior as a result, according to a new survey commissioned by Allergan plc. Th…

Read the full story

Tuesday, February 14, 2017 | Acquisitions and Mergers, PracticalDermatology.com, Allergan , Cool Sculpting, Cynosure, Profound, Syneron, Tattoo

In a Week of Surprising Acquisitions, Will Syneron Be Next?

Hot off the heels of Allergan’s acquisition of Zeltiq and Hologic Inc,’s surprising purchase of Cynosure Inc., media reports are now swirling that British private equity fund Apax Partners…

Read the full story

Monday, February 13, 2017 | Acquisitions and Mergers, Personnel/Company News, PracticalDermatology.com, Allergan , Cool Sculpting, Zeltiq

Allergan Agrees to Acquire ZELTIQ for $2.47 Billion

Allergan plc  and ZELTIQ® Aesthetics, Inc. have entered into a definitive agreement under which Allergan has agreed to acquire ZELTIQ for $56.50 per share, or $2.475 …

Read the full story

Wednesday, February 01, 2017 | Acquisitions and Mergers, Allergan

Allergan Completes LifeCell Aquisition

Allergan’s acquisition of LifeCell Corporation is in the books. The Botox maker completed the acquisition of LifeCell for approximately $2.9 billion in cash. The acquisition marks Allerg…

Read the full story

Friday, January 27, 2017 | PracticalDermatology.com, Product Launches and Updates, Allergan

Allergan Launches Juvéderm Volite

Allergan plc launched Juvéderm Volite, an injectable product specifically designed to improve skin quality and last up to nine months with just one treatment session. This innovative new Allerg…

Read the full story

Tuesday, January 03, 2017 | FDA Approval/Clearance, Product Launches and Updates, Allergan

FDA Approves Allergan's NATRELLE INSPIRA SoftTouch Breast Implants

The FDA granted Allergan plc approval to market Natrelle Inspira SoftTouch breast implants, offering women undergoing breast reconstruction, augmentation, or revision surgery a new medium firmness gel…

Read the full story

Tuesday, December 20, 2016 | Acquisitions and Mergers, Allergan

Business News: Allergan Acquires Lifecell

Allergan plc has acquired the regenerative medicine company LifeCell for $2.9 billion in cash, subject to customary adjustments, Allergan reports. This acquisition combines LifeCell's prod…

Read the full story